- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06353594
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI (COPERNICAN)
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With St-segment Elevation Myocardial Infarction (Copernican)
The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES) coronary revascularization in patients presenting with ST-segment myocardial infarction (STEMI).
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration. Random allocation in a 1:1 fashion to one of the following strategies:
- Study group: reduced stent PCI strategy (DCB-based)
- Control group: conventional PCI strategy (DES-based).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Naiara García Lamas
- Phone Number: 634213101
- Email: naiara@pinvestiga.com
Study Contact Backup
- Name: Marta Fernández Álvarez
- Phone Number: 604037828
- Email: marta@pinvestiga.com
Study Locations
-
-
-
Castelló, Spain
- Not yet recruiting
- Consorcio Hospitalario Provincial de Castellón
-
Contact:
- David Tejada Ponce, PI
-
Elche, Spain
- Not yet recruiting
- Hospital General Universitario de Elche
-
Contact:
- Paula Tejedor Viñuela, PI
-
Hospitalet de Llobregat, Spain
- Not yet recruiting
- Hospital Universitari de Bellvitge
-
Contact:
- Neus Salvatella Giralt, PI
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario 12 de octubre
-
Contact:
- Fernando Sarnago Cebada, PI
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario Puerta de Hierro Majadahonda
-
Contact:
- Juan F Oteo Domínguez, PI
-
Madrid, Spain
- Not yet recruiting
- Hospital Universitario de la Princesa
-
Contact:
- Fernando Rivero Crespo, PI
-
Málaga, Spain
- Not yet recruiting
- Hospital Universitario Regional de Málaga
-
Contact:
- Cristobal Urbano Carrillo, PI
-
Pamplona, Spain
- Not yet recruiting
- Hospital Universitario de Navarra
-
Contact:
- Guillermo Sánchez Elvira, PI
-
Sevilla, Spain
- Not yet recruiting
- Hospital Universitario Virgen del Rocio
-
Contact:
- José Díaz Fernández, PI
-
Tarragona, Spain
- Not yet recruiting
- Hospital Universitari Joan Xxiii de Tarragona
-
Contact:
- Mauricio Torres Sánchez, PI
-
Valencia, Spain
- Recruiting
- Consorcio Hospital General Universitario de Valencia
-
Contact:
- Eva Rumiz González, PI
-
Valladolid, Spain
- Not yet recruiting
- Hospital Clínico Universitario de Valladolid
-
Contact:
- Ignacio J Amat Santos, PI
-
Zaragoza, Spain
- Not yet recruiting
- Hospital Universitario Miguel Servet
-
Contact:
- Georgina A Fuertes Ferre
-
Zaragoza, Spain
- Not yet recruiting
- Hospital Clinico Universitario Lozano Blesa
-
Contact:
- Antonela Lukic Otanovic, PI
-
-
Comunidad Valenciana
-
Valencia, Comunidad Valenciana, Spain
- Recruiting
- Hospital Universitario y Politécnico La Fe
-
Contact:
- Jorge Sanz Sánchez, PI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients presenting with STEMI and indication to undergo pPCI.
Exclusion Criteria:
- Life expectancy <1 year due 1 to non-cardiac disease.
- Inability to provide informed consent.
- Cardiogenic shock.
- Left ventricular ejection fraction <15%.
- Left main disease.
- Stent thrombosis
- Patients with prior bypass graft lesions requiring PCI (culprit or non culprit lesions).
- Patients with chronic total occlusions.
- Untreatable coronary disease.
- Non-identified culprit lesion.
- Known allergy to aspirin, ticagrelor, prasugrel, clopidogrel, paclitaxel or sirolimus.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DCB-based
Reduced stent PCI strategy: Culprit lesion revascularization with DCB will be performed after coronary predilation if residual stenosis ≤30%, lack of dissections >type B and TIMI 3 flow.
If the aforementioned culprit-lesion characteristics are not achieved after DCB-PCI, a DES will be implanted.
|
Coronary percutaneous revascularization
|
No Intervention: DES-based
Control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Target lesion failure (TLF)
Time Frame: 12 months
|
Target-vessel myocardial infarction or ischemia-driven target-lesion revascularization
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of all-cause death
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of myocardial infarction
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of cardiovascular death
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of target lesion revascularization
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of stent thrombosis
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of acute vessel closure
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of stroke
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of acute kidney injury
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Incidence of bleeding
Time Frame: 10 years
|
Physicians Assessment
|
10 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jorge Sanz Sánchez, PI, Hospital Universitario La Fe
- Principal Investigator: Ignacio J Amat Santos, PI, Hospital Universitario de Valladolid
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COPERNICAN TRIAL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ST Elevation Myocardial Infarction
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Inha University HospitalCompletedST Segment Elevation Myocardial Infarction | Non-ST Segment Elevation Myocardial InfarctionKorea, Republic of
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
RenJi HospitalCompletedST Segment Elevation Myocardial Infarction
-
Dong-A UniversityTerminatedST-Segment Elevation Myocardial InfarctionKorea, Republic of
-
Azienda Ospedaliera San Camillo ForlaniniUnknownST Segment Elevation Myocardial InfarctionItaly
-
Jinan Central HospitalUnknownST-Segment Elevation Myocardial InfarctionChina
Clinical Trials on Primary PCI
-
Minneapolis Heart Institute FoundationNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Myocardial InfarctionUnited States
-
China-Japan Friendship HospitalRecruitingST Elevation Myocardial Infarction | Acute Coronary Syndrome | Percutaneous Coronary InterventionChina
-
Shanghai Zhongshan HospitalRecruitingST-segment Elevation Myocardial Infarction (STEMI)China
-
Samsun Education and Research HospitalCompleted
-
Italian Society of Invasive CardiologyMeditrial SrLCompletedAcute Myocardial InfarctionItaly
-
Qilu Hospital of Shandong UniversityCompletedMyocardial Infarction | Percutaneous Coronary Intervention | PRCPChina
-
Azienda Ospedaliero Universitaria Maggiore della...UnknownAcute Myocardial InfarctionItaly
-
Holger ThieleCompleted
-
Second Affiliated Hospital, School of Medicine,...Zhejiang University; First Affiliated Hospital of Wenzhou Medical University; Taizhou First People's Hospital and other collaboratorsAvailableST Elevation Myocardial InfarctionChina
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedMyocardial Infarction, AcuteMexico